Search results
Added:
7 months ago
Source:
Radcliffe CVRM
Patients receiving maintenance haemodialysis have a cardiovascular mortality rate more than 20 times higher than the general population, and many standard preventative therapies have proven ineffective in this high-risk group. The results of a new randomised clinical trial, PISCES, suggest that daily supplementation with fish oil could offer a significant benefit, substantially reducing the rate…
View more
Added:
2 years ago
Source:
European Renal Association
The SELECT Trial has revealed the potential of semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in combating kidney function decline among individuals with overweight or obesity and established cardiovascular disease but without diabetes.1Unveiling the results today at the 61st ERA Congress, researchers presented the impressive secondary analysis from the SELECT (Semaglutide…
View more